Sheryl Green
Icahn School of Medicine at Mount Sinai
GeneCancerInternal medicineRadiologySurgeryPathologyOncologyExternal beam radiotherapyDenaturing high performance liquid chromatographyChemotherapyBrain tumorMEDLINEProstate cancerRadiosurgeryPopulationNuclear medicineExonIncidence (epidemiology)Risk factorRadiation therapyBreast cancerMedicine
65Publications
17H-index
1,082Citations
Publications 64
Newest
Source
#1Jeremy Steinberger (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 13
#2Frank Yuk (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 13
Last. Isabelle M. Germano (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 37
view all 5 authors...
In the past 2 decades, a deeper understanding of the cancer molecular signature has resulted in longer longevity of cancer patients, hence a greater population, who potentially can develop metastatic disease. Spine metastases (SM) occur in up to 70% of cancer patients. Familiarizing ourselves with the key aspects of initial symptom-directed management is important to provide SM patients with the best patient-specific options. We will review key components of initial symptoms assessment such as p...
Source
Source
#1Tim Rattay (University of Leicester)H-Index: 8
#2Petra Seibold (DKFZ: German Cancer Research Center)H-Index: 27
Last. Sheryl GreenH-Index: 17
view all 119 authors...
Background: Acute skin toxicity is a common and usually transient side-effect of breast radiotherapy although, if sufficiently severe, it can affect breast cosmesis, aftercare costs and the patient's quality-of-life. The aim of this study was to develop predictive models for acute skin toxicity using published risk factors and externally validate the models in patients recruited into the prospective multi-center REQUITE (validating pREdictive models and biomarkers of radiotherapy toxicity to red...
1 CitationsSource
#1Anthony D. NehlsenH-Index: 1
Last. Sheryl GreenH-Index: 17
view all 4 authors...
Source
#1Michael Buckstein (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 12
#2Samantha Skubish (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 1
Last. Kenneth E. Rosenzweig (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 68
view all 6 authors...
Purpose/Objective(s): The COVID-19 pandemic is impacting all aspects of life and changing the practice of medicine. Multiple recommendations exist on how radiation oncology practices should deal with this crisis, but little information is available on what actually happens when the COVID-19 surge arrives. New York City experienced the first surge of COVID-19 in the United States and is now the epicenter of the global pandemic. This study reviews the impact of COVID-19 on a hospital system in New...
12 CitationsSource
#1Paolo De SanctisH-Index: 1
#2Sheryl Green (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 17
Last. Isabelle M. Germano (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 37
view all 3 authors...
Background Communicating hydrocephalus (cHCP) after radiosurgery (RS) for vestibular schwannomas (VS) has been reported. Many hypothetical mechanisms for this pathology have been proposed without consensus. The aim of this study is to determine if the platform used to treat the disease, Gamma Knife (GK) versus linear accelerator (LINAC)-based RS, makes a difference in outcome.
1 CitationsSource
#1Petra Seibold (DKFZ: German Cancer Research Center)H-Index: 27
#2A Webb (University of Leicester)H-Index: 9
Last. William Li (The Queen's Medical Center)H-Index: 1
view all 128 authors...
Abstract Purpose REQUITE aimed to establish a resource for multi-national validation of models and biomarkers that predict risk of late toxicity following radiotherapy. The purpose of this article is to provide summary descriptive data. Methods An international, prospective cohort study recruited cancer patients in 26 hospitals in eight countries between April 2014 and March 2017. Target recruitment was 5300 patients. Eligible patients had breast, prostate or lung cancer and planned potentially ...
15 CitationsSource
Source
#1Steven Lehrer (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 22
#2Sheryl Green (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 17
Last. Kenneth E. Rosenzweig (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 68
view all 5 authors...
BACKGROUND: Infiltrating lobular carcinoma (ILC) is the second most common histologicaI subtype of breast cancer, accounting for 10% of all cases. ILC has a characteristic genomic profile. ILC shows a high frequency of cadherin 1 (CDH1) mutations, along with loss of phosphatase and tensin homolog (PTEN), activation of alpha serine/threonine kinase (AKT), and mutations in T-box transcription factor (TBX3) and forkhead box protein A1 (FOXA1). We suspected that another gene, von Willebrand factor (...
4 CitationsSource